ALG3 and neoplasm: As shown in Figure 4C, the TKI (Tumor Killing Index) values for the anti-PD-1 group from the PDOTs cohort were ranked in descending order, and it was observed that patients with high ALG3 expression were predominantly clustered in the lower TKI value regions.